California Cancer Associates for Research & Excellence, Inc. — Encinitas, California

Public research footprint of California Cancer Associates for Research & Excellence, Inc., compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Colorectal Cancer · Breast Cancer · Non-Squamous Non-Small Cell Lung Cancer

Recently updated registry entries

NCT05464030 — Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) (Active Not Recruiting)
NCT02486718 — Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best… (Active Not Recruiting)
NCT02864992 — Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at California Cancer Associates for Research & Excellence, Inc.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.